Presidential speakers

Friday, June 12, 2026—Presidential Session I

Prof Franck Bourdeaut (France)

Cancer predisposition in children and adolescents

Prof Sonja Zweegman (Netherlands)

Regulatory approvals and novel trial endpoints: Learning from Multiple Myeloma treatment development

Prof Lars Bullinger (Germany)

From gene profiles to therapy profiles - a quarter century of molecular hematology

Prof Florent Ginhoux (France)

Macrophages - Guardians and culprits

Prof Pratima Chowdary (United Kingdom)

The future of hemophilia care: Entering an era of personalized medicine

Share